337 related articles for article (PubMed ID: 26745132)
1. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
2. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma.
Tang W; Nakamura Y; Tsujimoto M; Sato M; Wang X; Kurozumi K; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Mod Pathol; 2002 Jun; 15(6):593-8. PubMed ID: 12065771
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features].
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Chen ZX; Huang YH; Cai SR
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):609-11. PubMed ID: 15634522
[TBL] [Abstract][Full Text] [Related]
4. [mRNA expression of syndecan-1 and heparanase in relation to tumor progression and prognosis of gastric carcinoma].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1062-4. PubMed ID: 17074248
[TBL] [Abstract][Full Text] [Related]
5. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Cai SR; Ma JP
World J Gastroenterol; 2004 Mar; 10(6):776-82. PubMed ID: 15040016
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
7. [Relation of heparanase mRNA expression and angiogenesis to the progression of gastric carcinoma].
Ren XL; Zhu RZ; Wang LJ; Zhang ML; Li DH; Deng XQ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):368-71. PubMed ID: 12921569
[TBL] [Abstract][Full Text] [Related]
8. [Increased expression of heparanase mRNA is correlated with metastasis of gastric carcinoma and is probably correlated with c-met protein].
Cai YG; Fang DC; Yang SM; Luo YH; Yang MH; Wang DX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):974-8. PubMed ID: 15312528
[TBL] [Abstract][Full Text] [Related]
9. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features.
Cheng C; Lu X; Wang G; Zheng L; Shu X; Zhu S; Liu K; Wu K; Tong Q
APMIS; 2010 Nov; 118(11):855-63. PubMed ID: 20955458
[TBL] [Abstract][Full Text] [Related]
10. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
11. Heparanase expression correlates with invasion and poor prognosis in gastric cancers.
Takaoka M; Naomoto Y; Ohkawa T; Uetsuka H; Shirakawa Y; Uno F; Fujiwara T; Gunduz M; Nagatsuka H; Nakajima M; Tanaka N; Haisa M
Lab Invest; 2003 May; 83(5):613-22. PubMed ID: 12746471
[TBL] [Abstract][Full Text] [Related]
12. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
[TBL] [Abstract][Full Text] [Related]
14. Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma.
Wang Z; Xu H; Jiang L; Zhou X; Lu C; Zhang X
Mod Pathol; 2005 Feb; 18(2):205-11. PubMed ID: 15475937
[TBL] [Abstract][Full Text] [Related]
15. Heparanase gene expression and metastatic potential in human gastric cancer.
Endo K; Maejara U; Baba H; Tokunaga E; Koga T; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Nakajima M; Sugimachi K
Anticancer Res; 2001; 21(5):3365-9. PubMed ID: 11848495
[TBL] [Abstract][Full Text] [Related]
16. The association of HOTAIR expression with clinicopathological features and prognosis in gastric cancer patients.
Liu FT; Qiu C; Luo HL; Zhang Y; Xia GF; Hao TF; Zhu PQ
Panminerva Med; 2016 Jun; 58(2):167-74. PubMed ID: 26964077
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
19. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
[TBL] [Abstract][Full Text] [Related]
20. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
